vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and PHOTRONICS INC (PLAB). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $210.4M, roughly 1.3× PHOTRONICS INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 10.9%, a 85.5% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.4% vs -5.5%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs -3.8%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Photronics, Inc. is an American semiconductor photomask manufacturer. It was the third largest photomask supplier globally as of 2009. Photronics is a member of the eBeam Initiative.
ACAD vs PLAB — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $210.4M |
| Net Profit | $273.6M | $22.9M |
| Gross Margin | 90.8% | 33.7% |
| Operating Margin | 6.1% | 22.9% |
| Net Margin | 96.3% | 10.9% |
| Revenue YoY | 9.4% | -5.5% |
| Net Profit YoY | 90.3% | -32.4% |
| EPS (diluted) | $1.61 | $0.39 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0M | — | ||
| Q3 25 | $278.6M | $210.4M | ||
| Q2 25 | $264.6M | $211.0M | ||
| Q1 25 | $244.3M | $212.1M | ||
| Q4 24 | $259.6M | $222.6M | ||
| Q3 24 | $250.4M | $211.0M | ||
| Q2 24 | $242.0M | $217.0M | ||
| Q1 24 | $205.8M | $216.3M |
| Q4 25 | $273.6M | — | ||
| Q3 25 | $71.8M | $22.9M | ||
| Q2 25 | $26.7M | $8.9M | ||
| Q1 25 | $19.0M | $42.9M | ||
| Q4 24 | $143.7M | $33.9M | ||
| Q3 24 | $32.8M | $34.4M | ||
| Q2 24 | $33.4M | $36.3M | ||
| Q1 24 | $16.6M | $26.2M |
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | 33.7% | ||
| Q2 25 | 92.2% | 36.9% | ||
| Q1 25 | 91.7% | 35.6% | ||
| Q4 24 | 91.6% | 37.0% | ||
| Q3 24 | 92.5% | 35.6% | ||
| Q2 24 | 92.5% | 36.5% | ||
| Q1 24 | 88.8% | 36.6% |
| Q4 25 | 6.1% | — | ||
| Q3 25 | 12.8% | 22.9% | ||
| Q2 25 | 12.2% | 26.4% | ||
| Q1 25 | 7.9% | 24.6% | ||
| Q4 24 | 59.1% | 25.1% | ||
| Q3 24 | 12.6% | 24.7% | ||
| Q2 24 | 12.6% | 25.8% | ||
| Q1 24 | 7.4% | 26.6% |
| Q4 25 | 96.3% | — | ||
| Q3 25 | 25.8% | 10.9% | ||
| Q2 25 | 10.1% | 4.2% | ||
| Q1 25 | 7.8% | 20.2% | ||
| Q4 24 | 55.4% | 15.2% | ||
| Q3 24 | 13.1% | 16.3% | ||
| Q2 24 | 13.8% | 16.7% | ||
| Q1 24 | 8.0% | 12.1% |
| Q4 25 | $1.61 | — | ||
| Q3 25 | $0.42 | $0.39 | ||
| Q2 25 | $0.16 | $0.15 | ||
| Q1 25 | $0.11 | $0.68 | ||
| Q4 24 | $0.86 | $0.54 | ||
| Q3 24 | $0.20 | $0.55 | ||
| Q2 24 | $0.20 | $0.58 | ||
| Q1 24 | $0.10 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $575.8M |
| Total DebtLower is stronger | — | $16.0K |
| Stockholders' EquityBook value | $1.2B | $1.1B |
| Total Assets | $1.6B | $1.8B |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $177.7M | — | ||
| Q3 25 | $258.0M | $575.8M | ||
| Q2 25 | $253.6M | $558.4M | ||
| Q1 25 | $217.7M | $642.2M | ||
| Q4 24 | $319.6M | $640.7M | ||
| Q3 24 | $155.1M | $606.4M | ||
| Q2 24 | $177.1M | $559.9M | ||
| Q1 24 | $204.7M | $521.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $16.0K | ||
| Q2 25 | — | $19.0K | ||
| Q1 25 | — | $21.0K | ||
| Q4 24 | — | $25.0K | ||
| Q3 24 | — | $28.0K | ||
| Q2 24 | — | $2.5M | ||
| Q1 24 | — | $2.7M |
| Q4 25 | $1.2B | — | ||
| Q3 25 | $917.3M | $1.1B | ||
| Q2 25 | $822.4M | $1.1B | ||
| Q1 25 | $765.2M | $1.1B | ||
| Q4 24 | $732.8M | $1.1B | ||
| Q3 24 | $577.2M | $1.1B | ||
| Q2 24 | $516.7M | $1.0B | ||
| Q1 24 | $464.0M | $1.0B |
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.3B | $1.8B | ||
| Q2 25 | $1.2B | $1.7B | ||
| Q1 25 | $1.1B | $1.7B | ||
| Q4 24 | $1.2B | $1.7B | ||
| Q3 24 | $976.9M | $1.6B | ||
| Q2 24 | $914.1M | $1.6B | ||
| Q1 24 | $855.1M | $1.6B |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | $50.1M |
| Free Cash FlowOCF − Capex | — | $25.2M |
| FCF MarginFCF / Revenue | — | 12.0% |
| Capex IntensityCapex / Revenue | — | 11.8% |
| Cash ConversionOCF / Net Profit | -0.18× | 2.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $64.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.7M | — | ||
| Q3 25 | $74.3M | $50.1M | ||
| Q2 25 | $64.0M | $31.5M | ||
| Q1 25 | $20.3M | $78.5M | ||
| Q4 24 | $40.4M | $68.4M | ||
| Q3 24 | $63.2M | $75.1M | ||
| Q2 24 | $25.0M | $76.5M | ||
| Q1 24 | $29.1M | $41.5M |
| Q4 25 | — | — | ||
| Q3 25 | $73.9M | $25.2M | ||
| Q2 25 | — | $-29.1M | ||
| Q1 25 | — | $43.3M | ||
| Q4 24 | — | $25.2M | ||
| Q3 24 | $63.2M | $50.7M | ||
| Q2 24 | — | $56.5M | ||
| Q1 24 | — | $-1.8M |
| Q4 25 | — | — | ||
| Q3 25 | 26.5% | 12.0% | ||
| Q2 25 | — | -13.8% | ||
| Q1 25 | — | 20.4% | ||
| Q4 24 | — | 11.3% | ||
| Q3 24 | 25.2% | 24.0% | ||
| Q2 24 | — | 26.0% | ||
| Q1 24 | — | -0.8% |
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | 11.8% | ||
| Q2 25 | — | 28.7% | ||
| Q1 25 | — | 16.6% | ||
| Q4 24 | — | 19.4% | ||
| Q3 24 | 0.0% | 11.6% | ||
| Q2 24 | — | 9.2% | ||
| Q1 24 | — | 20.0% |
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | 2.19× | ||
| Q2 25 | 2.40× | 3.55× | ||
| Q1 25 | 1.07× | 1.83× | ||
| Q4 24 | 0.28× | 2.02× | ||
| Q3 24 | 1.93× | 2.18× | ||
| Q2 24 | 0.75× | 2.11× | ||
| Q1 24 | 1.76× | 1.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
PLAB
| High End Integrated Circuits | $53.6M | 25% |
| High End Flat Panel Displays | $53.5M | 25% |
| KR | $43.7M | 21% |
| Other | $42.1M | 20% |
| Mainstream Flat Panel Displays | $9.1M | 4% |
| Transferred At Point In Time | $8.4M | 4% |
